title: Ganglioside GM3 as a modulator of differentiation of mouse myeloid leukemia cells (M1-T22).
abstract: The effects of exogenously added glycosphingolipids on the differentiation of mouse myeloid leukemia cells (M1-T22) have been studied. Eight gangliosides and ten neutral glycosphingolipids were tested in terms of their induction of phagocytic activities on the leukemia cells. N-Acetyl-neuraminosyllactosylceramide (NAc-GM3) was the most effective glycolipid for inducing the activity. By the addition of 25 micrograms/ml of NAc-GM3, about 70 percent of the cells acquired phagocytic activity within 20 h incubation. GM1a showed about half the activity of the GM3. In the case of the neutral glycosphingolipids, lactosylceramide (CDH) and globotriaosylceramide (CTH) showed significant effects on the induction of phagocytic activity. Preincubation of the cells with the NAc-GM3 enhanced the effect of dexamethasone as a differentiation inducer on M1-T22 cells. When a human promyelocytic leukemia cell line, HL-60, was preincubated with the NAc-GM3 ganglioside, induction of the phagocytic activity, together with inhibition of the cell growth by phorbol ester (TPA), were markedly enhanced. From these observations, the NAc-GM3 ganglioside seems to act as a modulator of differentiation of mouse myeloid leukemia cells and also of HL-60 cells.
authors.affiliation: Department of Biochemistry, School of Pharmaceutical Science, University of Shizuoka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Arai
authors.forename: T
authors.initials: T
authors.lastname: Taki
authors.forename: A
authors.initials: A
authors.lastname: Kondo
authors.forename: M
authors.initials: M
authors.lastname: Matsumoto
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D003907:Dexamethasone / Q000494:pharmacology; D005679:G(M3) Ganglioside / Q000494:pharmacology*; D005732:Gangliosides / Q000378:metabolism / Q000494:pharmacology*; D005915:Globosides / Q000494:pharmacology; D006017:Glycolipids / Q000494:pharmacology; D006801:Humans; D007790:Lactosylceramides / Q000494:pharmacology; D007951:Leukemia, Myeloid / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000473:pathology; D051379:Mice; D010587:Phagocytosis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014281:Trihexosylceramides; D014407:Tumor Cells, Cultured
chemical_list: D005679:G(M3) Ganglioside; D005732:Gangliosides; D005915:Globosides; D006017:Glycolipids; D007790:Lactosylceramides; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D003907:Dexamethasone; D013755:Tetradecanoylphorbol Acetate